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ABSTRACT
RECQ5 DNA helicase suppresses homologous
recombination (HR) possibly through disruption of
RAD51 filaments. Here, we show that RECQ5 is con-
stitutively associated with the MRE11–RAD50–NBS1
(MRN) complex, a primary sensor of DNA double-
strand breaks (DSBs) that promotes DSB repair
and regulates DNA damage signaling via activation
of the ATM kinase. Experiments with purified pro-
teins indicated that RECQ5 interacts with the MRN
complex through both MRE11 and NBS1. Functional
assays revealed that RECQ5 specifically inhibited
the 3’!5’ exonuclease activity of MRE11, while
MRN had no effect on the helicase activity of
RECQ5. At the cellular level, we observed that the
MRN complex was required for the recruitment of
RECQ5 to sites of DNA damage. Accumulation of
RECQ5at DSBs was neither dependent on MDC1
that mediates binding of MRN to DSB-flanking chro-
matin nor on CtIP that acts in conjunction with MRN
to promote resection of DSBs for repair by HR.
Collectively, these data suggest that the MRN
complex recruits RECQ5 to sites of DNA damage
to regulate DNA repair.
INTRODUCTION
Proteins belonging to the RecQ DNA helicase family are
highly conserved from bacteria to mammals. In human
cells, ﬁve RecQ homologs have been identiﬁed and
named RECQ1, BLM, WRN, RECQ4 and RECQ5.
Inherited defects in the genes encoding for BLM, WRN
and RECQ4 have been found to cause distinct autosomal
recessive disorders associated with various forms of geno-
mic instability, premature aging and predisposition to
cancer (1). Numerous biochemical and cellular studies
have shown that the RecQ homologs in human cells
have nonredundant roles in the maintenance of genomic
stability (2). Several lines of evidence suggest that BLM
suppresses crossovers during homologous recombination
(HR) by acting in concert with DNA topoisomerase IIIa
to catalyze dissolution of double Holliday junctions (3,4).
WRN acts speciﬁcally at telomeres to promote lagging-
strand replication of G-rich telomeric regions, preventing
telomere erosion and subsequent recombination (5,6).
RECQ4 accumulates on chromatin during initiation of
DNA replication to promote loading of replication factors
at unwound origins (7,8).
The role of human RECQ5 protein in the maintenance
of genomic stability is not well understood. RECQ5 exists
in at least three diﬀerent isoforms resulting from alterna-
tive RNA splicing, but only the largest splice variant,
RECQ5b, localizes to the nucleus and possesses DNA
helicase activity (9–11). Like other RecQ helicases,
RECQ5b promotes branch migration of Holliday junc-
tions and exhibits strand-annealing and strand-exchange
activities in vitro (11,12). It can also disrupt RAD51 pre-
synaptic ﬁlaments in a reaction dependent on its ATPase
activity and the presence of replication protein A (RPA)
(13). In proliferating cells, RECQ5b associates with the
replication machinery and accumulates at sites of stalled
replication forks (12). Hereafter RECQ5b will be referred
to as RECQ5.
Mice lacking the Recql5 gene are viable, but are highly
prone to various types of cancer (13). Recql5-deﬁcient
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cells accumulate Rad51 and g-H2AX foci and are prone to
gross chromosomal rearrangements in response to replica-
tion stress (13). Moreover, Recql5 deﬁciency is associated
with a signiﬁcant increase in the frequency of both spon-
taneous and DNA-damage-induced HR (13,14). These
ﬁndings establish Recql5/RECQ5 as a tumor suppressor
that plays a role in the control of HR, possibly through dis-
ruption of inappropriately formed Rad51 ﬁlaments (13).
The MRE11–NBS1–RAD50 (MRN) complex exhibits
30!50 exonuclease activity on double-stranded (ds) DNA
and endonuclease activity on single-stranded (ss) DNA
and hairpin DNA structures in a reaction stimulated by
ATP (15). The nuclease active site resides in MRE11,
while RAD50 contains a bipartite ATP binding domain
split by a long repeat region that fold into an anti-parallel
coiled-coil domain (16). The coiled-coil domain of RAD50
can dimerize via a hook structure located on the tip of this
domain, which gives the MRN complex the capacity to
tether DNA ends (16,17). NBS1 does not possess any
enzymatic function, but it enhances the endonuclease
activity of the MRE11–RAD50 complex (18).
The MRN complex is required for the maintenance of
the integrity of DNA replication forks, double-strand
break (DSB) repair, G2/M checkpoint activation, telo-
mere length maintenance and meiotic recombination
(15,19). Accumulating evidence suggests that it functions
as a DSB sensor activating the ATM-dependent signaling
pathway, which coordinates cell cycle arrest with DNA
repair (20,21). In higher eukaryotes, null mutations in all
components of the MRN complex are lethal (19), while
hypomorphic mutations in the human MRE11 and NBS1
genes can give rise to Ataxia telangiectasia-like disorder
(ATLD) and Nijmegen breakage syndrome (NBS), respec-
tively, which are characterized by neurological abnormal-
ities, radiosensitivity, genomic instability and cancer
predisposition (19).
Here we show that RECQ5 and the MRN complex
constitutively associate in vivo and colocalize at nuclear
foci in response to replication arrest and chromosomal
breakage. The interaction between RECQ5 and MRN is
direct and can be mediated through both MRE11 and
NBS1. We further show that the recruitment of RECQ5
to sites of DNA damage is dependent on MRN.
Moreover, biochemical experiments reveal that RECQ5
inhibits the 30!50 exonuclease activity associated with
the MRE11 protein. Together, these data suggest a func-
tional relationship between RECQ5 and the MRN com-
plex in the cellular response to DNA damage.
MATERIALS AND METHODS
Protein purification
The RECQ5 protein was produced in bacteria as fusion
with self-cleaving chitin-binding domain (CBD) and pur-
iﬁed as described previously (11). Escherichia coli RecQ
was puriﬁed as described (22). Baculoviruses expressing
(His)6-MRE11, (His)6-NBS1 and RAD50, respectively,
were a kind gift from Dr Vilhelm Bohr. The MRN and
MR complexes as well as the individual MRN subunits
were produced in Sf9 cells infected with appropriate bacu-
loviruses. Cells harvested at 72 h after infection were sus-
pended in buﬀer A [50mM sodium phosphate (pH 7.0),
0.3M NaCl, 0.5% (v/v) Tween 20, 10% (v/v) glycerol,
2mM b-mercaptoethanol] supplemented with 20mM imi-
dazole and 2mM phenylmethylsulfonylﬂuoride (PMSF)
and disrupted by sonication. Cell extract was clariﬁed by
centrifugation at 100 000g for 1 h and loaded on a 5-ml
HiTrap Ni2+-Sepharose column (GE Healthcare) equili-
brated with buﬀer A containing 20mM imidazole. Bound
proteins were eluted with a linear concentration gradient
of imidazole (50ml; 50–350mM) in buﬀer A. Fractions
containing MRN proteins were pooled, dialyzed against
buﬀer B [20mM Tris–HCl (pH 8.0), 100mM NaCl, 10%
(v/v) glycerol and 1mM DL-Dithiothreitol (DTT)] and
loaded onto a 1-ml HiTrap Q Sepharose FF column
(GE Healthcare). Bound proteins were eluted with a
linear concentration gradient of NaCl (12ml; 50–
500mM) in buﬀer B. The RAD50 protein was puriﬁed
only via HiTrap Q Sepharose FF column as it was
expressed without a histidine tag. Puriﬁed proteins were
stored at 808C. The concentration of puriﬁed proteins
was determined by Bradford assay. The values obtained in
Bradford assay were divided by predicted molecular mass
of appropriate protein to calculate molar concentration.
The MRN complex was assumed to have an 2:2:1
(M:R:N) stoichiometry (23).
Antibodies
Rabbit polyclonal antibody against the C-terminal por-
tion of RECQ5 (amino acids 675–991) was aﬃnity puriﬁed
as described previously (12). Additionally, the following
commercially available antibodies were used in this study:
mouse monoclonal anti-MRE11 antibody, clone 12D7
(Novus Biologicals), mouse monoclonal anti-RAD50 anti-
body, clone 13B3 (GeneTex), rabbit polyclonal anti-NBS1
antibody, ab-398 (Abcam), mouse monoclonal anti-NBS1
antibody, clone 1D7 (GeneTex), mouse monoclonal
anti-g-H2AX antibody, clone JBW301 (Upstate
Biotechnology), rabbit polyclonal anti-TFIIH p89 anti-
body (S-19), sc-293 (Santa Cruz Biotechnology), mouse
monoclonal anti-RAD51 antibody, ab1837 (Abcam),
rabbit polyclonal anti-ATM antibody (Abcam), mouse
monoclonal anti-RPA antibody (Ab-3), clone RPA34-20
(Calbiochem), mouse monoclonal anti-Cyclin B1 anti-
body, clone GNS3 (Upstate) and mouse monoclonal
anti-CtIP antibody (24).
Cell culture and generation of DNA damage
U2OS, HeLa and HEK 293T cells were maintained in
Dulbecco modiﬁed Eagle’s medium (DMEM; OmniLab)
supplemented with 10% fetal calf serum (FCS; Life
Technologies) and streptomycin/penicillin (100U/ml).
Immortalized ATLD1 cells transduced with retrovirus
expressing the wild-type MRE11 cDNA (ATLD1-
MRE11) or retrovirus harboring the empty vector were a
kind gift from Dr Matthew Weitzman (25) and grown in
DMEM supplemented with 20% FCS, streptomycin/peni-
cillin (100U/ml) and 1 mg/ml puromycin (Sigma-Aldrich).
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NBS cells stably transfected with vector containing the
wild-type NBS1 cDNA (NBS-NBS1) as well as the parental
NBS cells (GM7166 VA7) were obtained from Dr Yosef
Shiloh and described in (26). Growth medium of comple-
mented NBS cells was supplemented with hygromycin B
(100 mg/ml). MDC1+/+ and MDC1/ mouse embryonic
ﬁbroblasts (MEFs) were cultured under the same condi-
tions as U2OS cells (27). Where indicated, cells were trea-
ted with 2mM hydroxyurea (HU) for 16 h or with 20 mM
cis-diamminedichloroplatinum (CDDP) for 8 h. Laser
microirradiation to generate DNADSBs in deﬁned nuclear
volumes was performed using a MMI CELLCUT system
containing a UVA laser of 355 nm (Molecular Machines &
Industries). Prior to irradiation, cells were grown for 24 h in
the presence of 10 mM bromodeoxyuridine (BrdU).
Ionizing radiation (IR) was generated using a Faxitron
X-ray system. UV irradiation (at a dose of 40 J/m2) was
performed in a UV-Stratalinker 1800 equipped with a
254 nm UV lamp (Stratagene). Immediately after expo-
sure to radiation, cells were placed back to incubator
and incubated for various periods of time as indicated.
For cell cycle analyses, ethanol-ﬁxed cells were stained
with propidium iodide (20mg/ml; Molecular Probes) and
subjected to ﬂow cytometry in a Becton Dickinson cell
sorter.
RNA interference
To knock down MRE11 expression in human cells, we
employed short-hairpin (sh) RNA technology. The oligo-
nucleotides shRNA-MRE11-top (50-gatccccacaggagaagag
atcaactttcaagagaagttgatctcttctcctgttttttggaaa-30) and
shRNA-MRE11-bottom 50-agcttttccaaaaaacaggagaagaga
tcaacttctcttgaaagttgatctcttctcctgtggg-30) were annealed
and ligated into the pSUPER vector (Oligoengine)
digested with HindIII and BglII (regions homologous to
the MRE11 sequence are underlined in each oligonucleo-
tide). For control RNAi experiments, the oligonucleotides
shRNA-C-top (50-gatccccagacgtgtacacaactagtttcaagagaact
agttgtgtacacgtcttttttggaaa-30) and shRNA-C-bottom (50-a
gcttttccaaaaaagacgtgtacacaactagttctcttgaaactagttgtgtacac
gtctggg-30) were annealed and processed as above. These
oligonucleotides were designed by scrambling of the
shRNA-MRE11 sequence within the MRE11 homology
region. The resulting plasmid constructs were further
modiﬁed by introducing a puromycin resistance marker.
To do so, the 1.4 kb BamHI/PvuI fragment of pPUR
(Clontech) was ligated into the BamHI and SmaI sites of
the pSUPER derivatives. The shRNA plasmids were
introduced into U2OS cells by liposomal transfection
with Metafectene (Biontex) that was carried out essentially
according to the manufacturer instructions. At 24 h
posttransfection, cell cultures were supplemented with
puromycin (2 mg/ml) to enhance the fraction of shRNA-
expressing clones. Cells were usually harvested 3 days
after addition of puromycin and analyzed as described
below.
The nucleotide sequences of CtIP and control (Ctrl)
siRNAs and siRNA transfection method were described
previously (24).
Immunofluorescence staining and analyses
Cells grown on cover slips were ﬁxed in methanol for
30min at 208C, which was followed by incubation in
acetone for 30 s. After blocking in PBS supplemented
with 2% FCS (blocking solution), cover slips were incu-
bated overnight at 48C with appropriate primary antibo-
dies [rabbit polyclonal anti-RECQ5 (1:1000) in
combination with either mouse monoclonal anti-RAD50
(1:200) or mouse monoclonal anti-g-H2AX (1:200); all
antibodies were diluted in blocking solution]. After wash-
ing with PBS, the cells were incubated with FITC-conju-
gated sheep anti-rabbit (Sigma; dilution of 1:700) and
Texas Red-conjugated donkey anti-mouse (Abcam; dilu-
tion of 1:200) secondary antibodies for 1 h at room tem-
perature. The cover slips were then mounted with
Vectashield (Vector Labs) and sealed. Images were taken
on an Olympus IX81 ﬂuorescence microscope and
acquired with a CCD camera (Orca AG, Hamamatsu)
using cellR software (Olympus). At least 150 nuclei were
analyzed in each experiment.
Immunoprecipitation assay
Cells grown in a 10-cm dish were subjected to trypsiniza-
tion, harvested by centrifugation and suspended in 0.5ml
of lysis buﬀer [50mM Tris–HCl (pH 8.0), 120mM NaCl,
20mM NaF, 15mM sodium pyrophosphate, 0.5mM
sodium orthovanadate and 0.5% (v/v) NP-40] supplemen-
ted with a protease inhibitor cocktail (Complete, Mini;
Roche). After a 30-min incubation on ice, the lysate was
treated with 50U of RNase-free DNase I (Roche) at 258C
for 30min, and clariﬁed by centrifugation. Cell extracts
(1mg) were incubated overnight at 48C with puriﬁed
rabbit anti-RECQ5 IgGs (1 mg) or with IgGs puriﬁed
from pre-immune serum (1 mg). Immune complexes were
subsequently incubated with protein A/G-agarose beads
(20ml, Santa Cruz Biotechnology) for 1 h at 48C. After
extensive washing with lysis buﬀer, beads were boiled in
SDS–PAGE loading buﬀer (25ml) for 10min to release
bound proteins. Immunoprecipitates were analyzed by
western blotting. For mass spectrometry (MS) analysis,
the immunoprecipitation protocol was scaled up to
include 10mg of total protein. The eluates from protein
A/G–agarose beads were concentrated using a speed-vac
before loading on a 7.5% (w/v) SDS-polyacrylamide gel.
Liquid chromatography-MS/MS analysis
SDS–PAGE gel was stained with Coomassie Brilliant Blue
and sample lanes were cut into 10 slices. Each slice was
further diced into smaller cubes (1mm) and subjected to
two cycles of rehydration in 50mM ammonium bicarbon-
ate (NH4HCO3) and dehydration in 80% (v/v) aceto-
nitrile. Gel pieces were then incubated with 37mM DTT
solution at 508C for 30min. After two additional rounds
of dehydration in 80% (v/v) acetonitrile, gel pieces were
incubated with 20mM iodoacetamide for 15min in dark
for protein alkylation. After another three rounds of rehy-
dration in 50mM NH4HCO3 and shrinking in 80% (v/v)
acetonitrile, the gel pieces were incubated with freshly
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diluted trypsin solution (12.5 ng/ml) at 378C for 4 h and
then at 258C overnight. Digested peptides were ﬁnally
extracted by 0.1% formic acid (one time) and 80% (v/v)
acetonitrile (three times) after which extracts were dried
under vacuum. The tryptic peptides were analyzed on a
Finnigan LCQ Deca (ThermoFisher, Basel Switzerland).
Prior to MS analysis, peptides were separated by an online
high-pressure liquid chromatograph (Agilent, Palo Alto,
CA) on a C18 reverse phase column using acetonitrile/
water system. MS/MS spectra were searched against the
human portion (taxonomy ID: 9606) of the UniProt data-
base (http://www.uniprot.org). The peptides identiﬁed
were interrogated using the Mascot search algorithm
(28). Mascot protein score of >45 was considered signiﬁ-
cant. Individual ions scores >41 indicate identity or exten-
sive homology (P <0.05).
CBD pull-down assay
CBD-tagged RECQ5 was produced in E. coli
BL21-CodonPlus(DE3)-RIL cells (Stratagene) as pre-
viously described (11). Cells harvested from a 10-ml cul-
ture were resuspended in 1ml of NET-150 buﬀer [10mM
Tris (pH 8.0), 1mM EDTA, 150mM NaCl, 10% (v/v)
glycerol and 0.1% (v/v) Triton X-100] supplemented
with a protease inhibitor cocktail (Complete, Mini;
Roche) and disrupted by sonication followed by centrifu-
gation at 20 000g for 45min. Clariﬁed cell extract (typi-
cally 50 ml) was incubated with 20 ml of chitin beads (NEB)
in a total volume of 400ml of NET-150 buﬀer for 2 h at
48C. After extensive washing with NET-150 buﬀer, beads
were incubated with recombinant MRN proteins (1 mg) in
400ml of NET-150 buﬀer supplemented with ethidium
bromide (50 mg/ml) for 2 h at 48C. Bound proteins were
analyzed by western blotting.
Strand exchange assay
Strand exchange assays with RECQ5 were performed
essentially as described previously (12). Brieﬂy, reactions
were carried at 378C in buﬀer containing 20mM Tris–
acetate (pH 7.9), 50mM KOAc, 10mM Mg(OAc)2,
1mM DTT and 50 mg/ml BSA. 1 nM DNA substrates
(60-mer/30-mer partial duplex and complementary
60-mer oligonucleotide, of which the former 60-mer oligo-
nucleotide was radiolabeled at 50 end) were preincubated
with 40 nM RECQ5 for 10min to form a forked duplex.
RECQ5-mediated strand exchange between the arms of
the fork was initiated by addition of ATP (2mM).
Where required, the annealing mixture was preincubated
with 40 nM MRN complex for 5min prior to addition of
ATP. Aliquots (5ml) from diﬀerent reaction time points
were subjected to electrophoresis in 10% nondenaturing
polyacrylamide gel (acrylamide/bis-acrylamide 19:1) run
in 1xTBE buﬀer at 140V. Gels were dried and subjected
to phosphor-imaging analysis using a Typhoon 9400
scanner.
Nuclease assay
The 30!50 exonuclease activity of the MR(N) complex
was measured using a 50-tailed oligoduplex prepared by
annealing of a 30-mer oligonucleotide (50-ggagtaaagt
actaggtatgtcgacattga-30) to the 30-half of a 60-mer oligo-
nucleotide (50-gaggtcactccagtgaattcgagctcgcagtcaatgtcgac
atacctagtactttactcc-30). The 30-mer oligonucleotide was
radiolabeled at the 50-end prior to annealing. Reactions
were conducted at 378C in buﬀer containing 30mM
MOPS (pH 7.0), 25mM KCl, 1mM DTT, 2mM MnCl2,
2mM ATP and 50 mg/ml BSA. Reaction mixtures con-
tained 1 nM DNA substrate, 40 nM MR(N) and varying
concentrations of RECQ5 or E. coli RecQ, ranging from 0
to 80 nM. MR(N) and RECQ5 (or RecQ) were preincu-
bated for 5min on ice before adding to the DNA sub-
strate. Reactions were terminated after 30min by adding
an equal volume of stop solution [80% (v/v) formamide,
10mM EDTA, 0.1% (w/v) bromophenol blue and 0.1%
(w/v) xylene cyanol] and heating at 958C for 5min.
Reaction aliquots were subjected to electrophoresis in
15% (w/v) polyacrylamide gel containing 8M urea (acry-
lamide/bis-acrylamide 19:1) run in 1xTBE buﬀer at 300V.
Gels were dried and subjected to phosphor-imaging ana-
lysis using a Typhoon 9400 scanner. DNA bands in the gel
images were quantiﬁed using ImageQuant software
(Molecular Dynamics).
RESULTS
Physical interaction between RECQ5 and the MRN
complex
To identify proteins associated with RECQ5 in vivo, we
performed large-scale immunoprecipitation combined
with mass spectrometric analysis. Using aﬃnity-puriﬁed
rabbit polyclonal anti-RECQ5 antibody, we immunopre-
cipitated RECQ5 from whole cell extract of HEK 293T
cells containing 10mg of protein. IgG puriﬁed from pre-
immune serum was used as the negative control. The
immunoprecipitated proteins were separated by SDS–
PAGE and visualized by Coomassie Blue staining
(Figure S1). The lane containing RECQ5 immunoprecipi-
tate was cut into 10 slices and proteins in each slice
were identiﬁed by MS as described in Materials and
Methods section. This analysis revealed a number of
potential RECQ5 interactors involved in DNA metabo-
lism (Figure S1 and Table 1). Our attention was in
particular drawn to the MRN complex, a nuclease that
plays a pivotal role in the recognition and repair of
DSBs (20,21).
To verify the MS data, the RECQ5 immunoprecipitate
from 293T cells was subjected to western blot analysis
using antibodies against the individual MRN subunits.
We found that this immunoprecipitate contained a large
fraction of the endogenous MRN proteins, whereas the
control immunoprecipitate obtained with IgG isolated
from a pre-immune rabbit serum was devoid of these pro-
teins (Figure 1A, compare lanes 1–3). The amount of
MRN detected in RECQ5 immunoprecipitates from cell
lysates pre-treated with DNaseI or ethidium bromide was
comparable with that detected in RECQ5 immunoprecipi-
tate from nontreated lysate, indicating that the observed
association of RECQ5 with MRN proteins is DNA inde-
pendent (Figure 1A; compare lanes 3, 4 and 5). We also
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performed a reciprocal co-immunoprecipitation experi-
ment using anti-MRE11 antibody. We found that
MRE11 immunoprecipitate from HeLa cells contained a
signiﬁcant amount of RECQ5 (Figure 1B). Collectively,
these data indicate that a fraction of the MRN complex
stably associates with RECQ5 in vivo.
Next, we compared the levels of the MRE11 protein in
RECQ5 immunoprecipitates from cells exposed with var-
ious genotoxic agents including HU, IR and CDDP. This
experiment revealed that the cellular level of the RECQ5–
MRN complex is not signiﬁcantly aﬀected by DNA
damage, suggesting that DNA damage does neither
induce nor prevent the formation of the RECQ5–MRN
complex in vivo (Figure S2A, compare lanes 2–4 with
lane 1). We also examined the levels of RECQ5–MRN
complex at diﬀerent stages of the cell cycle. To do so,
U2OS cells were synchronized at G1/S transition by HU
treatment and then released into drug-free medium. Cells
were collected at diﬀerent time points after the removal
of HU and subjected to immunoprecipitation with
anti-RECQ5 antibody. In a parallel experiment, cell popu-
lations from the individual time points were subjected
to FACS analysis to determine the stage of the cell
cycle (Figure S2C). We found that the level of the
RECQ5–MRN complex remained constant throughout
the cell cycle, suggesting a constitutive association
(Figure S2B).
To determine whether RECQ5 and MRN interact
directly, we performed aﬃnity pull-down assays with pur-
iﬁed recombinant proteins. RECQ5 was expressed in bac-
teria as a fusion with a CBD tag and bound to chitin
beads. The beads were subsequently incubated with pur-
iﬁed MRN and MR complexes, respectively, that were
produced in insect cells by means of baculovirus system.
We found that both complexes were avidly bound to
RECQ5 beads, but not to control beads coated with
CBD, suggesting that the interaction between RECQ5
and MRN observed in vivo is direct and independent of
NBS1 (Figure 2A).
In an attempt to further deﬁne the interaction site for
RECQ5 on the MRN complex, we tested individually pur-
iﬁed MRN subunits for binding to RECQ5–CBD beads.
Interestingly, we found that both MRE11 and NBS1, but
not RAD50, were bound to RECQ5, suggesting that the
interaction between RECQ5 and the MRN complex is
mediated not only by MRE11 but also by NBS1
(Figure 2B). To substantiate these ﬁndings, we performed
immunoprecipitation experiments with total cell extracts
from NBS and ATLD1 cells carrying hypomorphic muta-
tions in the NBS1 and MRE11 genes, respectively. We
found that the RECQ5 immunoprecipitate from NBS
cells contained both MRE11 and RAD50 proteins in sim-
ilar concentrations as the RECQ5 immunoprecipitate
Table 1. A selection of proteins identiﬁed by mass spectrometric analysis of the RECQ5 immunoprecipitate from 293T cells
Protein Swiss-Prot
entry
Sequence
coverage (%)
Number of
peptides
Mascot
protein scorea
RECQ5b O94762 18.0 57 347
MRE11b P49959 13.7 43 257
RAD50b Q92878 20.1 120 253
NBS1b O60934 6.1 18 157
DNA-dependent protein kinase catalytic subunit (DNA-PKcs)b P78527 15.5 160 1354
RECQ4b O94761 5.2 26 111
MCM7b P33993 20.4 44 251
RNA polymerase II largest subunit RPB1b P24928 25.6 240 1602
RNA polymerase II subunit 2 (RPB2) P30876 12.7 43 315
Nucleolin P19338 11.4 13 109
E3 ubiquitin–protein ligase EDD1 (UBR5) O95071 3 25 370
aMascot protein score of >45 was considered signiﬁcant.
bConﬁrmed by immunoblotting (IB).
The full list is available upon request.
Figure 1. RECQ5 associates with the MRN complex in vivo. (A)
Co-immunoprecipitation of the MRE11, RAD50 and NBS1 proteins
with RECQ5 from total extract of 293T cells (1mg of protein). Lane 1,
5% of the input material; lane 2, immunoprecipitation using
IgG (1 mg) isolated from a preimmune serum; lane 3, immunoprecipi-
tation with aﬃnity-puriﬁed rabbit anti-RECQ5 antibody (1 mg); lane 4,
the same as lane 3, but the extract was pretreated with DNase I
(50U) for 30min at 258C; lane 5, the same as lane 3, but
extract was supplemented with ethidium bromide (50 mg/ml). (B)
Co-immunoprecipitation of RECQ5 with the MRE11 protein
from total extract of HeLa cells. Lane 1, 5% of the input material;
lane 2, immunoprecipitation using IgG (1mg) isolated from a pre-
immune serum; lane 3, immunoprecipitation using mouse monoclonal
anti-MRE11 antibody (1mg). (A and B) Immunoprecipitated proteins
were analyzed by SDS–PAGE followed by IB using antibodies
described in Materials and Methods section.
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from NBS cells complemented with the wild-type NBS1
cDNA, conﬁrming that RECQ5 binds to the MR complex
in a manner independent of NBS1 (Figure 2C, lanes 1, 2, 5
and 6). In ATLD1 cells, the levels of NBS1 and RAD50
proteins were dramatically reduced as previously reported
(29). However, a small amount of NBS1 could still be
detected in the RECQ5 immunoprecipitate from these
cells, indicating that NBS1 can interact with RECQ5
in absence of MRE11 (Figure 2C, lane 7). In
MRE11-complemented ATLD1 cells, expression of all
three subunits of the MRN complex could again be readily
detected by western blot (Figure 2C, lane 4). Accordingly,
the RECQ5 immunoprecipitate from total extract of these
cells was found to contain substantial amounts of all three
MRN proteins (Figure 2C, lane 8).
RECQ5 inhibits the 3’!5’ exonuclease activity ofMRN
complex
Next, we investigated whether the interaction between
RECQ5 and the MRN complex aﬀects the biochemical
activities of these proteins. The SDS–PAGE proﬁle of
the puriﬁed proteins used in this study is shown in
Figure S3. First, we tested the eﬀect of MRN on the heli-
case activity of RECQ5. Previous studies demonstrated
that RECQ5 displays a poor 30!50 helicase activity on
oligonucleotide-based partial duplexes due to a strong
strand-annealing activity residing in the C-terminal half
of RECQ5 (11). However, RECQ5 could eﬃciently dis-
place the lagging-strand oligonucleotide from synthetic
forked structures with homologous arms where reanneal-
ing of this oligonucleotide is prevented by annealing of the
parental strands (12). Thus, we evaluated the eﬀect of the
MRN complex on this strand-exchange reaction. We
found that the rate of RECQ5-mediated strand-exchange
was not altered upon addition of the MRN complex, sug-
gesting that the MRN complex does not modulate the
helicase activity of RECQ5 (Figure S4).
Since the MRN complex has been shown to possess
30!50 exonuclease activity (15), we tested the eﬀect of
RECQ5 on MRN-mediated exonucleolytic processing of
a 30-bp duplex with a 50-ssDNA tail containing 30 nt. Our
initial experiments showed that the MRN complex
required manganese and ATP as cofactors to exhibit eﬃ-
cient 30!50 exonuclease activity on this DNA substrate
(data not shown), which is consistent with previously pub-
lished data (18,30). Addition of RECQ5 to this reaction
resulted in a signiﬁcant decrease in the exonuclease activ-
ity of MRN (Figure 3A, lanes 3–7, and 3C). We did not
observe the same eﬀect with the E. coli RecQ helicase,
excluding the possibility that the inhibition of the
MRE11 nuclease by RECQ5 results from competition
between these proteins for the DNA substrate
(Figure 3B, lanes 3–7, and 3C).
To investigate whether the inhibition of exonuclease
activity of MRN by RECQ5 is dependent on the presence
of the NBS1 protein, we evaluated the eﬀect of RECQ5 on
the exonuclease activity of the MR complex. The MR
complex displayed a similar exonuclease activity as the
MRN complex (Figure 3A and B, compare lanes 3 and
8, and C). Most importantly, RECQ5, but not RecQ, was
found to inhibit the MR-mediated exonucleolytic proces-
sing (Figure 3A and B, lanes 8–12, and C).
Collectively, these data indicate that RECQ5 inhibits
the exonuclease activity of MRN most likely as a result
of its binding to MRE11.
RECQ5 and theMRN complex colocalize at sites of DNA
damage
To explore a potential role for RECQ5–MRN interaction
in the maintenance of genomic stability, we analyzed the
spatial relationship of these proteins in the nucleus of
U2OS cells in response to various types of DNA
damage including stalled replication forks, DNA adducts
and DSBs. After individual DNA-damaging treatments,
cell were ﬁxed with methanol, co-immunostained with
anti-RECQ5 and anti-RAD50 antibodies and analyzed
Figure 2. RECQ5 and the MRN complex interact directly. (A) Binding
of puriﬁed MRN (‘top panel’) and MR (‘bottom panel’) complexes to
chitin beads coated with RECQ5–CBD fusion. (B) Binding of individ-
ually puriﬁed RAD50 (‘top panel’), NBS1 (‘middle panel’) and MRE11
(‘bottom panel’) proteins to chitin beads coated with RECQ5–CBD
fusion. For (A) and (B): lane 1, 30% of input material; lane 2, chitin
beads coated with CBD; lane 3, chitin beads coated with RECQ5–CBD
fusion protein. Binding reactions were carried out as described in
Materials and Methods section. (C) Western blot analysis of RECQ5
immunoprecipitates from total extracts of the following cells: NBS
(NBS1 deﬁciency), NBS1+ (NBS complemented by stable transfection
of the NBS1 cDNA), ATLD1 (MRE11 deﬁciency) and ATLD1+
(ATLD1 complemented by stable transfection of the MRE11 cDNA).
Lanes 1–4, 5% of the input material as indicated, lanes 5–8, RECQ5
immunoprecipitates from total extracts (1mg of protein) of the indi-
cated cells. Blots were probed for the presence of RECQ5, MRE11,
RAD50 and NBS1 using antibodies described in Materials and
Methods section.
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by ﬂuorescence microscopy. As expected, in majority of
unperturbed cells, both RECQ5 and RAD50 were uni-
formly distributed in the nucleus (Figure 4A, top row).
After HU treatment, which results in replication arrest
due to depletion of deoxyribonucleotides, both RECQ5
and RAD50 formed bright nuclear foci that extensively
colocalized in >70% of cells (Figure 4A, middle row).
Moreover, RECQ5 and RAD50 partially colocalized
after exposure of cells to UVC light (40 J/m2) that can
stall the progression of replication forks through induc-
tion of bulky DNA lesions (Figure 4A, bottom row).
Thus, it is possible that RECQ5 and the MRN complex
cooperate in the processing of stalled replication forks.
To generate DSBs, U2OS cells were presensitized by
incorporation of BrdU into genomic DNA and then
locally exposed to UVA light (355 nm) using micro-laser
technology, which results in linear tracks of DSBs across
each irradiated nucleus (31). These tracks can be detected
by immunoﬂuorescence imaging of phosphorylated his-
tone H2AX (g-H2AX) that is rapidly generated in the
DSB-ﬂanking chromatin by the ATM kinase (32). We
found that RECQ5 started to accumulate at DSB tracks
as early as 15min after irradiation, reaching maximal
levels at about 30min after irradiation, and persisted at
those sites as long as 1 h after irradiation (Figure 4B, top
panel). Double staining for RECQ5 and RAD50 further
conﬁrmed these ﬁndings (Figure 4B, bottom panel).
Like MRN, RECQ5 was found to accumulate at micro-
irradiated areas essentially in all g-H2AX-positive cells
(150 cells evaluated), suggesting that the recruitment of
RECQ5 to DSBs is not restricted to any particular
phase of the cell cycle. To conﬁrm this assumption, micro-
irradiated cells were doubly stained for RECQ5 and cyclin
B1. We found that RECQ5 accumulated in the microirra-
diated nuclear regions in cyclin B1-positive cells (cells in S
and G2) as well as in cells lacking any detectable amount
of cyclin B1 (cells in G1) (Figure 4C). These data indicate
that RECQ5 accumulates at DSBs throughout the
interphase.
TheMRN complex is required for the recruitment of
RECQ5 to sites of replication arrest
As the MRN complex is well known to function as a DNA
damage sensor, we tested the possibility that it mediates
the recruitment of RECQ5 to sites of DNA damage. First,
we evaluated the eﬀect of MRE11 deﬁciency on the focal
distribution of RECQ5 after HU treatment. To do so, we
silenced the expression of the MRE11 gene in U2OS cells
Figure 3. RECQ5 inhibits the 30!50 exonuclease activity of MR(N). (A) Eﬀect of RECQ5 on the 30!50 exonuclease activity of MRN (lanes 3–7) and
MR (lanes 8–12). (B) Eﬀect of E. coli RecQ on the 30!50 exonuclease activity of MRN (lanes 3–7) and MR (lanes 8–12). In (A) and (B), reaction
mixtures were incubated at 378C for 30min, and contained 1 nM 50-tailed oligoduplex substrates (60-mer/30-mer with a 50-32P label on the shorter
strand), 40 nM MRN or MR and various concentrations of RECQ5 or RecQ as indicated. Reaction products were analyzed by denaturing PAGE
followed by phosphorimaging as described in Materials and Methods section. (C) Quantiﬁcation of the gels shown in (A) and (B). Intensity of the
DNA substrate band in each lane was measured using ImageQuant software. The obtained values were used to calculate the percentage of cleaved
DNA. The values obtained for the reactions carried out in the absence of MR(N) were taken as 100% in these calculations. The data points
represent the mean of three independent experiments.
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using shRNA. We observed a dramatic reduction in the
cellular level of MRE11 protein following puromycin
selection for cells expressing anti-MRE11 shRNA con-
struct, whereas no reduction in MRE11 levels was
observed in cells harboring the control construct expres-
sing a scrambled shRNA (Figure 5A). Depletion of
MRE11 by shRNA also dramatically reduced the cellular
level of RAD50, which is consistent with low levels of
RAD50 found in ATLD1 cells, but it did not aﬀect the
level of RECQ5 (Figure 5A, lane 2 and Figure 2C, lane 3).
Importantly, we found that shRNA-mediated depletion of
MRE11 in U2OS cells completely abolished the formation
of RECQ5 foci after HU treatment (Figure 5B, top panel).
In contrast, HU-treated U2OS cells expressing the control
shRNA contained both RECQ5 and RAD50 foci that
showed extensive colocalization (Figure 5B, bottom
panel, top row). Essentially the same results were obtained
with ATLD1 and ATLD1-MRE11 cells (Figure 5C).
Further, the MRE11-proﬁcient and MRE11-deﬁcient
cells were doubly stained for RECQ5 and g-H2AX.
Histone H2AX is phosphorylated in response to replica-
tion arrest in ATR-dependent manner and forms nuclear
foci that colocalize with PCNA and hence can serve as
markers for stalled replication forks (33,34). As expected,
in 70% of MRE11-proﬁcient cells treated with HU,
RECQ5 extensively colocalized with g-H2AX at bright
nuclear foci (Figure 5B and C, bottom panels, bottom
rows). MRE11-deﬁcient cells also displayed g-H2AX
foci in response to HU treatment (Figure 5B and C, top
panels, bottom rows). However, RECQ5 foci were not
seen in these cells.
TheMRN complex is required for the recruitment of
RECQ5 to DSBs
To evaluate whether MRE11 is required for the recruit-
ment of RECQ5 to DSBs, we microirradiated ATLD1
cells with UVA laser and stained them for RECQ5 and
g-H2AX at 30min after irradiation. We found that none
of g-H2AX-positive ATLD1 cells contained RECQ5
tracks (Figure 6, top panel). In contrast, accumulation
of RECQ5at irradiated areas was seen in ATLD1-
McRE11 cells (Figure 6, top panel). Collectively, these
data indicate that the recruitment of RECQ5 to DSBs is
dependent on a functional MRN complex.
The MRN complex has multiple functions in the cellu-
lar response to DSBs. Following activation of the ATM
kinase by MRN bound to DNA ends, more MRN accu-
mulates in large chromatin domains ﬂanking DSBs, which
Figure 4. RECQ5 and RAD50 colocalize at sites of DNA damage. (A) Indirect immunoﬂuorescence imaging of RECQ5 and RAD50 in U2OS cells
prior to and after DNA replication arrest. Cells were either left untreated or incubated in the presence of HU for 16 h or exposed to UV light at a
dose of 40 J/m2 followed by incubation for 6 h. After genotoxic treatments, cells were ﬁxed with methanol and triply stained for RECQ5 (green),
RAD50 (red) and DNA (blue) as described in Materials and Methods section. Overlap between the green and red signals in merged images appears
yellow. (B) RECQ5 and RAD50 accumulate at laser-induced DNA DSBs. U2OS cells were sensitized with BrdU (10 mM; incubation for 24 h) and
subjected to microirradiation with pulsed UVA laser (=355nm) to generate linear tracks of DSBs. At indicated time points after irradiation, cells
were ﬁxed with methanol and co-immunostained either with anti-RECQ5 (green) and anti-g-H2AX (red) antibodies or with anti-RECQ5 (green) and
anti-RAD50 (red) antibodies as indicated. DAPI (blue) was used to stain nuclei. (C) U2OS cells were treated as in (B) and 30min postirradiation,
co-immunostained with antibodies against RECQ5, g-H2AX (to detect microirradiated tracks) and cyclin B1 (to reveal cells in S/G2). g-H2AX and
cyclin B1 are displayed in the same channel (red). DAPI (blue) was used to stain nuclei.
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is likely to enhance the DSB-induced signal by means of
a positive feedback loop (32). Recruitment of MRN to
DSB-ﬂanking chromatin is critically dependent on
MDC1 that forms a complex with MRN in a manner
dependent on CK2 phosphorylation and directly interacts
with g-H2AX in the damaged chromatin (35–38). To
address whether MDC1 is required for the recruitment
of RECQ5 to sites of DSBs, we compared DSB-
induced nuclear traﬃcking of RECQ5 in MDC1+/+ and
MDC1/ MEFs. We found that MDC1 deﬁciency had
no eﬀect on the recruitment of RECQ5 to laser-induced
DSB tracks (Figure 6, middle panel). Although this ﬁnd-
ing does not exclude the possibility that a fraction of the
RECQ5 protein associate with DSB-ﬂanking chromatin
as a part of the MRN–MDC1 complex, it argues that
MRN recruits RECQ5 to broken DNA ends. In both
MDC1-proﬁcient and MDC1-deﬁcient MEFs, >97% of
irradiated nuclei (out of at least 100 nuclei) contained
RECQ5-positive tracks, further supporting the notion
that RECQ5 associates with DSBs in a cell-cycle indepen-
dent manner (data not shown).
MRN, in conjunction with CtIP, promotes resection of
DSBs that arise during S/G2 phases of the cell cycle, gen-
erating 30-ssDNA tails for HR repair (24). To address the
question whether the recruitment of RECQ5 to DSBs
occurs as a consequence of DSB resection, we depleted
CtIP from U2OS cell by means of RNA interference
(Figure S5A). Cells were ﬁxed at 30min after laser micro-
irradiation and stained with anti-RECQ5 in combination
with either anti-g-H2AX or anti-RPA antibodies. We
found that CtIP depletion had no eﬀect on accumulation
of RECQ5 at DSB tracks (Figure 6, bottom panel).
In contrast, accumulation of RPA at microirradiated
areas was completely abolished upon CtIP depletion
(Figure S5B) as previously reported (24). These data indi-
cate that the observed MRE11-dependent accumulation of
RECQ5at DSB sites is not dependent on DSB resection.
DISCUSSION
HR provides the most accurate mechanism for the repair
of DSBs and ssDNA gaps which frequently occur in the
cell as a result of collision of the DNA replication machin-
ery with DNA lesions and other obstacles or as a result of
processing of DNA lesions by DNA repair enzymes
(39,40). In mitotic cells, most recombination intermediates
are processed through pathways such as synthesis-
dependent strand annealing (SDSA) or double-Holliday
junction (dHJ) dissolution that do not result in crossovers.
These mechanisms are important for avoidance of poten-
tially deleterious chromosomal rearrangements that can
arise if the homologous sequence used for HR-mediated
repair is located at diﬀerent chromosomal locus. A key
step in HR is the formation of a RAD51-ssDNA ﬁlament
Figure 5. MRE11 is required for the recruitment of RECQ5 to arrested replication forks. (A) Western blot analysis of extracts of U2OS cells
expressing indicated shRNAs. Cells were transfected with appropriate shRNA vector and subjected to puromycin selection for 3 days to enrich the
population of transfected cells. Blots were probed for MRE11, RAD50, RECQ5, RAD51, ATM and TFIIH (loading control) using antibodies
described in Materials and Methods section. Lane 1, extract from cells expressing control shRNA (Ctrl shRNA); lane 2, extract from cells expressing
shRNA targeting the MRE11 transcript (MRE11 shRNA). (B) Eﬀect of shRNA-mediated depletion of MRE11 in U2OS cells on nuclear distribution
of RECQ5 in response to HU. Cells were transfected either with the plasmid expressing Ctrl shRNA (‘bottom panel’) or the plasmid expressing
MRE11 shRNA (‘top panel’), followed by puromycin selection. Two days after addition of puromycin, HU was added to a ﬁnal concentration of
2mM. After 16 h, cells were ﬁxed and co-immunostained either for RECQ5 (green) and RAD50 (red) or for RECQ5 (green) and g-H2AX (red) as
indicated. (C) Nuclear distribution of RECQ5 in ATLD1 (‘top panel’) and ATLD1-MRE11 (‘bottom panel’) cells after replication arrest by HU.
Exponentially growing cells were treated with 2mM HU for 16 h and then ﬁxed and co-immunostained either for RECQ5 (green) and RAD50 (red)
or for RECQ5 (green) and g-H2AX (red) as indicated.
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that mediates the search for sequence homology and
associates with the donor sequence forming the so-called
D-loop structure (39). Recent studies indicated that the
RECQ5 DNA helicase counteracts the formation of cross-
overs during HR (13,14). Moreover, it has been shown
that RECQ5 has the ability to disrupt RAD51 nucleopro-
tein ﬁlaments in vitro (13). However, the importance of
this activity in the regulation of HR in vivo still remains
to be explored. Furthermore, it is not clear by now how
RECQ5 is recruited to the sites of HR.
Here we show that RECQ5 interacts with the MRN
complex, a key player in the repair of DNA damage by
HR. Our results suggest that this interaction is mediated
through MRE11 and NBS1. At the biochemical level,
RECQ5 speciﬁcally inhibited the 30!50 exonuclease activ-
ity of the MRN and MR complexes, suggesting that
RECQ5 interacts with the nuclease or DNA-binding
domains of MRE11 thereby impairing the access of
MRE11 to the DNA substrate. At the cellular level,
MRE11 was required for the accumulation of RECQ5at
sites of arrested replication forks and sites of DSBs.
Interestingly, recruitment of RECQ5 to DSBs was not
dependent on MDC1, which mediates chromatin retention
of MRN at sites of DNA damage (35,36). Moreover,
RECQ5 accumulation at DSBs was not aﬀected upon
depletion of CtIP, indicating that it is not dependent on
the DNA-end resection of DSBs in S/G2 generating
30-ssDNA tails to initiate repair by HR (24). Instead,
our data argue that RECQ5 migrates to and acts at
broken DNA ends as a part of the MRN complex.
In the budding yeast Saccharomyces cerevisiae, the for-
mation of crossovers during HR is counteracted mainly by
the Srs2 DNA helicase, which has no obvious sequence
homologs in higher eukaryotes (41,42). Like RECQ5, Srs2
has the capacity to disrupt Rad51 ﬁlaments formed on
ssDNA (43,44). Srs2 also shows preference for unwinding
of D-loop structures, and its helicase activity is stimulated
by Rad51 ﬁlaments on dsDNA, supporting the proposed
role for Srs2 in promoting SDSA (45). Strikingly, Srs2 has
been shown to physically interact with the DNA-binding
domain of Mre11 (46). This, together with our ﬁnding of a
physical interaction between RECQ5 and the MRN com-
plex in human cells, lends further support to the hypoth-
esis that RECQ5 is a functional ortholog of Srs2 (13).
Moreover, our data might explain how these anti-recom-
binases are delivered to sites of DNA repair. However, the
precise role of the MRN complex in the function of these
proteins during HR still remains to be addressed.
Interestingly, we have found that RECQ5 accumulates
at DSBs throughout the interphase. A recent study
demonstrated that RAD51 accumulates at laser-induced
damage sites not only in S/G2 phase, where DSBs are
repaired by HR, but also in G1 phase where HR repair
is suppressed (47). Thus, it is possible that one function of
RECQ5 is to prevent RAD51-mediated HR events in G1
cells that could lead to detrimental chromosomal rearran-
gements because of the lack of an undamaged sister
chromatid.
We found that MRE11 was required for the RECQ5
focus formation in response to replication arrest by HU.
Given the role for MRN as a DSB sensor, one can assume
that these foci represent broken replication forks under-
going HR repair. However, HU-induced DNA DSBs
become apparent only after 24 h of continuous HU treat-
ment (48). In contrast, RECQ5 foci could readily be
observed at 16 h following addition of HU, suggesting
that they rather represent sites of stalled replication
forks. Previous studies indicated that the MRN complex
is associated with replication forks throughout S-phase via
phosphorylation-dependent interaction with RPA
(49–51). It was also shown that the MRN complex colo-
calizes with RPA in response to replication arrest by HU
(48,52). Thus, it is possible that the MRN complex tethers
RECQ5 to ssDNA regions generated at stalled replication
forks to prevent formation of RAD51 ﬁlaments and
subsequent DNA recombination. Such a ‘fork clearing’
function was proposed for the E. coliUvrD DNA helicase,
a bacterial ortholog of Srs2, based on ﬁnding that the
lethality conferred by uvrD deletion to certain replication
mutants is suppressed by inactivation of the genes
involved in the RecFOR pathway of HR (53,54). There
is also evidence suggesting that Srs2 prevents
Figure 6. MRE11, but not MDC1 and CtIP, is required for the recruit-
ment of RECQ5 to laser-induced DSBs. Indicated cell lines were irra-
diated with UVA laser at 24 h following addition of BrdU (10 mM),
ﬁxed at 30min after the irradiation and co-immunostained to visualize
RECQ5 (green) and g-H2AX (red). DAPI (blue) was used to stain
nuclei. For U2OS cell cultures, BrdU was added 2 days after transfec-
tion of CtIP or control (Ctrl) siRNA.
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recombination events at stalled replication forks favoring
lesion bypass by translesion polymerases or through tem-
plate-switching mechanism (55,56).
The BLM helicase also suppresses crossover events
during HR as evidenced by elevated rate of sister chroma-
tid exchanges (SCEs) and increased incidence of loss of
heterozygocity in BLM-deﬁcient cells relative to normal
cells (1). Recent studies demonstrated that, out of
human RecQ helicases, only BLM could promote dHJ
dissolution, suggesting that BLM is the human counter-
part of the yeast Sgs1 helicase (3,4,41). Although there is
also some evidence suggesting that BLM functions in the
SDSA pathway of HR, genetic studies using mutant
mouse cells clearly indicated that BLM and RECQ5
have nonredundant roles in suppression of crossovers,
which is similar to the situation of Srs2 and Sgs1 in
yeast (14,41,57).
A recent study suggested that the human F-box helicase
1 (FBH1), which is conserved in Schizosaccharomyces
pombe, but not in S. cerevisiae, is a functional ortholog
of Srs2. It was shown that FBH1 shares homology with
Srs2 within the helicase domain and suppresses speciﬁc
recombination defects of S. cerevisiae srs2 mutants (58).
Although it remains to be determined whether FBH1 pos-
sesses the ability to displace RAD51 from ssDNA, the
existence of both Fbh1 and Srs2 in S. pombe rather sug-
gests that these two helicases use diﬀerent mechanisms to
suppress recombination. This is further supported by the
synthetic lethality of mutations in these genes, which is
suppressed by deletion of the recombination gene rhp57
(59). Fbh1 is also essential for viability in absence of
Rqh1, the sole RecQ homolog of S. pombe (59).
Simultaneous inactivation of the FBH1 and BLM homo-
logs in chicken DT40 cells is not lethal, but it results in
much higher frequency of SCE relative to SCE levels in
the respective single mutants (59). Thus, it seems that
BLM, RECQ5 and FBH1 act rather in a complementary
fashion during processing of HR intermediates. Since
FBH1 helicase can function as the substrate speciﬁcity
subunit of an SCF ubiquitin ligase complex one can spec-
ulate that it regulates recombination by triggering proteo-
lytic degradation of recombination factors (60).
RECQ5 is not the sole human RecQ helicase that inter-
acts with the MRN complex. There is evidence for a func-
tional link between MRN and BLM. Similar to Sgs1,
BLM was found to coexist with MRN in a large complex
containing proteins involved in the recognition and repair
of aberrant DNA structures, although no evidence for a
direct BLM–MRN interaction was reported (61). It was
also shown that BLM and MRN colocalize at nuclear foci
in response to replication stress and that BLM is required
for the relocalization of MRN to sites of replication arrest
(61,62). Previous studies also demonstrated that the MRN
complex physically interacts with WRN, which is required
for the resolution of HR intermediates (63–65). Moreover,
these studies revealed that the relocalization of WRN to
sites of DNA damage is dependent on a functional MRN
complex (63,64). However, WRN and RECQ5 diﬀer in the
mode of their interaction with MRN. The formation of
WRN–MRN complex in vivo is dependent on DNA
damage (63,64), whereas, based on our data, RECQ5
appears to constitutively interact with MRN in vivo.
The interaction between WRN and the MRN complex is
solely mediated by NBS1 (63), while we show that RECQ5
can bind to both MRE11 and NBS1 and that the absence
of NBS1 does not aﬀect the association of RECQ5 with
the MR complex. At the functional level, MRN dramati-
cally stimulates the helicase activity of WRN (63), whereas
it has no eﬀect on the helicase activity of RECQ5. Further
studies will deﬁnitely be needed to understand the molecu-
lar mechanisms underlying the cooperation between RecQ
DNA helicases and the MRN complex in the biological
processes that enforce genomic stability.
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